Your browser doesn't support javascript.
loading
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation.
Hendrick, Charles E; Jorgensen, Jeff R; Chaudhry, Charu; Strambeanu, Iulia I; Brazeau, Jean-Francois; Schiffer, Jamie; Shi, Zhicai; Venable, Jennifer D; Wolkenberg, Scott E.
Afiliação
  • Hendrick CE; Discovery Chemistry, Therapeutics Discovery, Janssen Research & Development, LLC,Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States.
  • Jorgensen JR; Discovery Technology and Molecular Pharmacology, Therapeutics Discovery, Janssen Research & Development, LLC, Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States.
  • Chaudhry C; Discovery Technology and Molecular Pharmacology, Therapeutics Discovery, Janssen Research & Development, LLC, Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States.
  • Strambeanu II; Discovery Chemistry, Therapeutics Discovery, Janssen Research & Development, LLC,Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States.
  • Brazeau JF; Discovery Chemistry, Therapeutics Discovery, Janssen Research & Development, LLC, 3210 Merryfield Row, La Jolla, California 92121, United States.
  • Schiffer J; Computational Chemistry, Therapeutics Discovery, Janssen Research & Development, LLC, 3210 Merryfield Row, La Jolla, California 92121, United States.
  • Shi Z; Discovery Chemistry, Therapeutics Discovery, Janssen Research & Development, LLC,Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States.
  • Venable JD; Discovery Chemistry, Therapeutics Discovery, Janssen Research & Development, LLC, 3210 Merryfield Row, La Jolla, California 92121, United States.
  • Wolkenberg SE; Discovery Chemistry, Therapeutics Discovery, Janssen Research & Development, LLC,Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States.
ACS Med Chem Lett ; 13(7): 1182-1190, 2022 Jul 14.
Article em En | MEDLINE | ID: mdl-35859867
ABSTRACT
A platform to accelerate optimization of proteolysis targeting chimeras (PROTACs) has been developed using a direct-to-biology (D2B) approach with a focus on linker effects. A large number of linker analogs-with varying length, polarity, and rigidity-were rapidly prepared and characterized in four cell-based assays by streamlining time-consuming steps in synthesis and purification. The expansive dataset informs on linker structure-activity relationships (SAR) for in-cell E3 ligase target engagement, degradation, permeability, and cell toxicity. Unexpected aspects of linker SAR was discovered, consistent with literature reports on "linkerology", and the method dramatically speeds up empirical optimization. Physicochemical property trends emerged, and the platform has the potential to rapidly expand training sets for more complex prediction models. In-depth validation studies were carried out and confirm the D2B platform is a valuable tool to accelerate PROTAC design-make-test cycles.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article